Aline Delva^#^1 2, Michel Koole^#³, Kim Serdons⁴, Guy Bormans⁵, Longbin Liu⁶, Jonathan Bard⁶, Vinod Khetarpal⁶, Celia Dominguez⁶, Ignacio Munoz-Sanjuan⁶, Andrew Wood⁶, Mette Skinbjerg⁶, Yuchuan Wang⁶, Wim Vandenberghe^#^1 2, Koen Van Laere^#^7 8

Affiliations

¹Department of Neurosciences, KU Leuven, Leuven, Belgium.

²Department of Neurology, University Hospitals Leuven, Leuven, Belgium.

³Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.

⁴Department of Radiopharmacy, University Hospitals Leuven, Leuven, Belgium.

⁵Lab Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

⁶CHDI Management/CHDI Foundation, Princeton, NJ, 08540, USA.

⁷Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. koen.vanlaere@uzleuven.be.

⁸Division of Nuclear Medicine, University Hospitals Leuven, Leuven, België. koen.vanlaere@uzleuven.be.

^#Contributed equally.

Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [11C]CHDI-00485180-R and [11C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin

Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [¹¹C]CHDI-00485180-R and [¹¹C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin